ISSN: 0950-9240
Journal Home
Journal Guideline
Journal of Human Hypertension Q2 Unclaimed
Journal of Human Hypertension is a journal indexed in SJR in Internal Medicine with an H index of 103. It has a price of 3190 €. It has an SJR impact factor of 0,723 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,723.
Journal of Human Hypertension focuses its scope in these topics and keywords: hypertension, blood, pressure, patients, dash, intervention, selfmanagement, essential, consistent, fourth, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,723
SJR Impact factor103
H Index232
Total Docs (Last Year)388
Total Docs (3 years)8661
Total Refs1043
Total Cites (3 years)314
Citable Docs (3 years)2.46
Cites/Doc (2 years)37.33
Ref/DocOther journals with similar parameters
European Journal of Internal Medicine Q2
Journal of Diabetes and its Complications Q2
American Journal of Hypertension Q2
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Q2
Diabetes and Vascular Disease Research Q2
Compare this journals
Aims and Scope
Best articles by citations
Anti-atherosclerotic efficacy of olmesartan
View moreHypertension and renovascular disease: follow-up on 100 renal vein renin samplings
View morePost exercise hypotension is not mediated by the serotonergic system in borderline hypertensive individuals
View moreFreehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study
View morePolymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study
View moreTilt test alters accuracy of the oscillometric device Omron HEM-705CP
View moreUpdate on the use of calcium antagonists on hypertension
View moreComparison of the antihypertensive effects of the fixed dose combination enalapril 10mg/nitrendipine 20mg vs losartan 50mg/hydrochlorothiazide 12.5mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients
View moreHypertension in a patient with Gitelman's syndrome
View moreOxidative stress in white coat hypertension; role of paraoxonase
View moreHypertension in Brazil
View moreEffect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor
View moreFixed dose combination therapy in the treatment of hypertension
View moreArterial hypertension increases left ventricular mass: role of tight blood pressure control
View moreAn association between smoking habits and blood pressure in normotensive Japanese men
View moreHealth-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE)
View moreAntihypertensive efficacy of olmesartan compared with other antihypertensive drugs
View moreEndothelial dysfunction in patients with white coat hypertension
View moreEndothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists
View moreIs there an epidemic of primary aldosteronism?
View moreArterial stiffness in diabetes and hypertension
View moreImpact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study
View moreEpidemiology of hypertension and its associated risk factors in the Qatari population
View moreEnhanced vasodilator responses to calcitonin gene-related peptide (CGRP) in subcutaneous arteries in human hypertension
View more
Comments